長期投資家のためのIR情報
バリュートレンド

【2796】ファーマライズホールディングス
調剤薬局。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.05 2026/09/17 Q1予 70,604 → 0.0% 0.0% 1,014 → 0.0% 0.0% 736 → 0.0% 0.0% 11 → 0.0% 0.0%
2027.05 2026/06/25 当初予 70,604 - - - 1,014 - - - 736 - - - 11 - - -
2026.05 2026/06/25 実 69,512 ↑ +4.1% +4.1% 979 ↓ -12.8% -12.8% 715 ↓ -24.0% -24.0% 114 ↓ -57.1% -57.1%
2026.05 2026/03/19 Q3予 66,795 → 0.0% 0.0% 1,123 → 0.0% 0.0% 941 → 0.0% 0.0% 266 → 0.0% 0.0%
2026.05 2025/12/25 Q2予 66,795 → 0.0% 0.0% 1,123 → 0.0% 0.0% 941 → 0.0% 0.0% 266 → 0.0% 0.0%
2026.05 2025/09/25 Q1予 66,795 → 0.0% 0.0% 1,123 → 0.0% 0.0% 941 → 0.0% 0.0% 266 → 0.0% 0.0%
2026.05 2025/06/25 当初予 66,795 - - - 1,123 - - - 941 - - - 266 - - -
2025.05 2025/06/25 実 63,508 ↓ -1.9% +4.3% 293 ↓ -16.3% -69.1% 136 ↓ -4.9% -83.1% -367 ↓ -71.5% -1017.5%
2025.05 2025/03/25 Q3予 64,734 → 0.0% +6.3% 350 → 0.0% -63.1% 143 → 0.0% -82.2% -214 → 0.0% -635.0%
2025.05 2024/12/25 Q2予 64,734 ↑ +6.3% +6.3% 350 ↓ -63.1% -63.1% 143 ↓ -82.2% -82.2% -214 ↓ -635.0% -635.0%
2025.05 2024/09/25 Q1予 60,880 → 0.0% 0.0% 949 → 0.0% 0.0% 804 → 0.0% 0.0% 40 → 0.0% 0.0%
2025.05 2024/06/28 当初予 60,880 - - - 949 - - - 804 - - - 40 - - -
2024.05 2024/06/28 実 54,466 → 0.0% +1.7% 916 → 0.0% -38.0% 833 ↓ -0.2% -41.5% -351 ↓ -36.6% -178.2%
2024.05 2024/06/14 修正予 54,466 ↑ +0.7% +1.7% 916 ↓ -13.3% -38.0% 835 ↓ -14.6% -41.3% -257 ↓ -253.0% -157.2%
2024.05 2024/03/25 Q3予 54,086 ↑ +1.0% +1.0% 1,056 ↓ -28.5% -28.5% 978 ↓ -31.3% -31.3% 168 ↓ -62.6% -62.6%
2024.05 2023/12/25 Q2予 53,546 → 0.0% 0.0% 1,477 → 0.0% 0.0% 1,423 → 0.0% 0.0% 449 → 0.0% 0.0%
2024.05 2023/10/02 Q1予 53,546 → 0.0% 0.0% 1,477 → 0.0% 0.0% 1,423 → 0.0% 0.0% 449 → 0.0% 0.0%
2024.05 2023/07/11 当初予 53,546 - - - 1,477 - - - 1,423 - - - 449 - - -
2023.05 2023/07/11 実 52,030 ↑ +0.5% +0.2% 1,438 ↑ +1.9% -10.5% 1,431 ↑ +3.8% -8.3% 333 ↓ -16.1% -38.7%
2023.05 2023/03/30 Q3予 51,794 → 0.0% -0.2% 1,411 → 0.0% -12.1% 1,379 → 0.0% -11.7% 397 → 0.0% -26.9%
2023.05 2022/12/29 Q2予 51,794 ↓ -0.2% -0.2% 1,411 ↓ -12.1% -12.1% 1,379 ↓ -11.7% -11.7% 397 ↓ -26.9% -26.9%
2023.05 2022/10/13 Q1予 51,909 → 0.0% 0.0% 1,606 → 0.0% 0.0% 1,561 → 0.0% 0.0% 543 → 0.0% 0.0%
2023.05 2022/07/08 当初予 51,909 - - - 1,606 - - - 1,561 - - - 543 - - -
2022.05 2022/07/08 実 51,608 ↓ -3.1% -3.1% 1,520 ↑ +1.1% +1.1% 1,517 ↑ +5.1% +5.1% 447 ↑ +2.1% +2.1%
2022.05 2022/04/12 Q3予 53,238 → 0.0% 0.0% 1,503 → 0.0% 0.0% 1,444 → 0.0% 0.0% 438 → 0.0% 0.0%
2022.05 2022/01/13 Q2予 53,238 → 0.0% 0.0% 1,503 → 0.0% 0.0% 1,444 → 0.0% 0.0% 438 → 0.0% 0.0%
2022.05 2021/10/14 Q1予 53,238 → 0.0% 0.0% 1,503 → 0.0% 0.0% 1,444 → 0.0% 0.0% 438 → 0.0% 0.0%
2022.05 2021/07/15 当初予 53,238 - - - 1,503 - - - 1,444 - - - 438 - - -
2021.05 2021/07/15 実 52,324 ↑ +0.8% -3.2% 1,246 ↑ +5.0% +6.8% 1,288 ↑ +9.9% +15.8% 426 ↑ +12.7% +13.3%
2021.05 2021/04/14 Q3予 51,927 → 0.0% -3.9% 1,187 → 0.0% +1.7% 1,172 → 0.0% +5.4% 378 → 0.0% +0.5%
2021.05 2021/01/14 Q2予 51,927 ↓ -3.9% -3.9% 1,187 ↑ +1.7% +1.7% 1,172 ↑ +5.4% +5.4% 378 ↑ +0.5% +0.5%
2021.05 2020/10/15 Q1予 54,041 → 0.0% 0.0% 1,167 → 0.0% 0.0% 1,112 → 0.0% 0.0% 376 → 0.0% 0.0%
2021.05 2020/07/15 当初予 54,041 - - - 1,167 - - - 1,112 - - - 376 - - -
2020.05 2020/07/15 実 51,030 ↓ -1.1% -2.8% 1,034 ↑ +14.3% +20.5% 1,023 ↑ +20.4% +30.0% 577 ↑ +47.6% +454.8%
2020.05 2020/04/13 Q3予 51,598 → 0.0% -1.7% 905 → 0.0% +5.5% 850 → 0.0% +8.0% 391 → 0.0% +276.0%
2020.05 2020/01/14 Q2予 51,598 ↓ -1.5% -1.7% 905 ↑ +4.3% +5.5% 850 ↓ -0.1% +8.0% 391 ↓ -0.3% +276.0%
2020.05 2019/10/11 Q1予 52,370 ↓ -0.3% -0.3% 868 ↑ +1.2% +1.2% 851 ↑ +8.1% +8.1% 392 ↑ +276.9% +276.9%
2020.05 2019/07/16 当初予 52,508 - - - 858 - - - 787 - - - 104 - - -
2019.05 2019/07/16 実 51,728 ↓ -1.5% -1.5% 640 ↑ +62.0% +62.0% 590 ↑ +118.5% +118.5% 23 ↑ +111.2% +111.2%
2019.05 2019/04/12 Q3予 52,500 → 0.0% 0.0% 395 → 0.0% 0.0% 270 → 0.0% 0.0% -205 → 0.0% 0.0%
2019.05 2019/01/15 Q2予 52,500 → 0.0% 0.0% 395 → 0.0% 0.0% 270 → 0.0% 0.0% -205 → 0.0% 0.0%
2019.05 2018/10/12 Q1予 52,500 → 0.0% 0.0% 395 → 0.0% 0.0% 270 → 0.0% 0.0% -205 → 0.0% 0.0%
2019.05 2018/07/13 当初予 52,500 - - - 395 - - - 270 - - - -205 - - -
2018.05 2018/07/13 実 54,562 ↓ -0.1% -0.1% 1,179 ↑ +16.2% +16.2% 1,092 ↑ +22.7% +22.7% -28 ↓ -113.7% -113.7%
2018.05 2018/04/13 Q3予 54,600 → 0.0% 0.0% - - - - 890 → 0.0% 0.0% 205 → 0.0% 0.0%
2018.05 2018/01/12 Q2予 54,600 → 0.0% 0.0% 1,015 → 0.0% 0.0% 890 → 0.0% 0.0% 205 → 0.0% 0.0%
2018.05 2017/10/13 Q1予 54,600 → 0.0% 0.0% 1,015 → 0.0% 0.0% 890 → 0.0% 0.0% 205 → 0.0% 0.0%
2018.05 2017/07/14 当初予 54,600 - - - 1,015 - - - 890 - - - 205 - - -
2017.05 2017/07/14 実 52,949 ↑ +0.9% +1.8% 442 ↓ -11.6% -45.4% 324 ↓ -8.7% -49.4% 7 ↓ -86.0% -93.0%
2017.05 2017/04/14 Q3予 52,500 ↑ +1.9% +1.0% 500 ↓ -15.3% -38.3% 355 ↓ -19.3% -44.5% 50 ↓ -54.5% -50.0%
2017.05 2017/01/13 Q2予 51,500 ↓ -1.0% -1.0% 590 ↓ -27.2% -27.2% 440 ↓ -31.3% -31.3% 110 ↑ +10.0% +10.0%
2017.05 2016/10/14 当初予 52,000 - - - 810 - - - 640 - - - 100 - - -
2016.05 2016/07/13 実 - - - - - - - - - - - - - - - -
2016.05 2016/04/12 Q3予 48,500 ↑ +3.2% +15.5% 975 ↓ -23.2% -27.0% 755 ↓ -26.3% -34.9% 515 ↓ -20.8% +53.7%
2016.05 2016/01/13 Q2予 47,000 → 0.0% +11.9% 1,270 → 0.0% -4.9% 1,025 → 0.0% -11.6% 650 → 0.0% +94.0%
2016.05 2016/01/12 修正予 47,000 ↑ +11.9% +11.9% 1,270 ↓ -4.9% -4.9% 1,025 ↓ -11.6% -11.6% 650 ↑ +94.0% +94.0%
2016.05 2015/10/13 Q1予 42,000 → 0.0% 0.0% 1,335 - - - 1,160 → 0.0% 0.0% 335 → 0.0% 0.0%
2016.05 2015/07/14 当初予 42,000 - - - - - - - 1,160 - - - 335 - - -
2015.05 2015/07/14 実 - - - - - - - - - - - - - - - -
2015.05 2015/04/14 Q3予 39,600 → 0.0% +0.3% 1,230 → 0.0% +20.6% 1,020 → 0.0% +27.5% 250 → 0.0% +100.0%
2015.05 2015/01/14 Q2予 39,600 → 0.0% +0.3% 1,230 → 0.0% +20.6% 1,020 → 0.0% +27.5% 250 → 0.0% +100.0%
2015.05 2015/01/08 修正予 39,600 ↑ +0.3% +0.3% 1,230 ↑ +20.6% +20.6% 1,020 ↑ +27.5% +27.5% 250 ↑ +100.0% +100.0%
2015.05 2014/10/15 Q1予 39,500 → 0.0% 0.0% 1,020 → 0.0% 0.0% 800 → 0.0% 0.0% 125 → 0.0% 0.0%
2015.05 2014/07/15 当初予 39,500 - - - 1,020 - - - 800 - - - 125 - - -
2014.05 2014/07/15 実 38,221 ↑ +0.8% +0.8% 1,572 ↑ +15.6% +15.6% 1,272 ↑ +17.8% +17.8% 369 ↓ -10.0% -10.0%
2014.05 2014/04/14 当初予 37,920 - - - 1,360 - - - 1,080 - - - 410 - - -
シェア ツイート
ページトップへ戻る